Market access rebates and discounts for brand medicines by component U.S. 2013-2020
In 2020, market access rebates and discounts as a subcomponent of gross expenditures for brand medicines accounted for more than 102 billion U.S. dollars in the United States. The statistic illustrates the total market access rebates and discounts for brand medicines by components from 2013 to 2020, by component.